Renaturation method of COVID-19 recombinant protein inclusion bodies
A coronavirus and recombinant protein technology, applied in the biological field, can solve problems such as low recovery rate, large amount of protein precipitation, shortening the time and cost required for renaturation of recombinant protein inclusion bodies, etc.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2020-07-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, and relates to a method for renaturation of a novel coronavirus recombinant protein inclusion body. Background technique
[0002] The new type of coronavirus (SARS-CoV-2, or COVID-19) is a new strain of coronavirus first discovered in humans in 2019. It belongs to the same β-coronavirus as SARS coronavirus, and the two have high homology 80%. Different from the common cold or flu, the new coronavirus mainly causes lower respiratory tract infection, causing symptoms such as fever, cough, weakness, and difficulty breathing, posing a serious threat to public health.
[0003] At present, the effective detection methods for the new coronavirus are PCR detection of viral nucleic acid and detection of serum virus antibody IgM / IgG. Existing viral nucleic acid detection kits for PCR detection of viral nucleic acid have high cost and long detection cycle. However, through the detection of serum virus antibo...
Examples
Embodiment 1
[0042] Example 1 Novel coronavirus RBD recombinant protein expression and inclusion body renaturation
[0043] 1. Expression of novel coronavirus RBD recombinant protein
[0044] (1) A BamH I restriction site is introduced into the N-terminus of the novel coronavirus RBD protein, and an Xho I restriction site is introduced into the C-terminus to obtain the novel coronavirus RBD recombinant protein. According to the gene sequence encoding the RBD recombinant protein of the new coronavirus, synthetic primers were designed for PCR amplification. After the PCR amplification product was purified, the PCR amplification product of the gene encoding the RBD recombinant protein of the new coronavirus was obtained. Among them, the full gene sequence of the novel coronavirus RBD protein is shown in SEQ ID NO: 1, the upstream primer for PCR amplification is: acacggatccAGAGTCCAACCAACAGAATC (SEQ ID NO: 3), and the downstream primer is: agagctcgagGAAATTGACACATTTGTTTTTAACC (SEQ ID NO: 4).
...
Embodiment 2
[0059] Example 2 Expression of novel coronavirus N recombinant protein and renaturation of inclusion bodies
[0060] Including the following steps:
[0061] (1) A Sac I restriction site was introduced into the N-terminus of the N protein of the novel coronavirus, and 6*His and Not I restriction sites were introduced into the C-terminus to obtain the recombinant protein of the novel coronavirus N. According to the gene sequence encoding the new coronavirus N recombinant protein, synthetic primers are designed for PCR amplification. After the PCR amplification product is purified, the PCR amplification product of the coding gene of the new coronavirus N recombinant protein is obtained. Among them, the new coronavirus N protein The whole gene sequence is shown in SEQ ID NO:2, the upstream primer for PCR amplification is: tgtcgagctcATGTCTGATAATGGACCC (SEQ ID NO:5), and the downstream primer is: gagtgcggccgcTTAGTGATGGTGGTGATGGTGGGCCTGAGTTGAGTCAGC (SEQ ID NO:6).
[0062] (2) The PC...